The Versatility of Lateral Chest Wall Perforator Flaps in Immediate and Delayed Breast Reconstruction: Retrospective Study of Clinical Experience with 26 Patients.

Rationale: Lateral chest flaps represent versatile reconstructive options, especially valuable in times of global healthcare resource restriction. In this series, we present our experience with the use of lateral chest wall flaps in both immediate and delayed reconstruction from both breast conserving and mastectomy surgery. Methods: A retrospective cohort study of patients who had undergone a lateral chest wall flap for immediate or delayed breast reconstruction of a lumpectomy or mastectomy defect was performed. Data collected consisted of patient demographics, procedure type, tumor/oncological characteristics, as well as postoperative complications. Findings: Between September 2015 and April 2021, 26 patients underwent breast reconstruction using a lateral chest wall flap. Fifteen patients (58%) underwent immediate reconstruction (9 lumpectomy; 6 mastectomy) and 11 (42%) underwent delayed breast reconstruction. All flaps survived, though 1 patient required partial flap debridement following venous compromise hours after surgery. There were no incidences of hematoma, seroma, infection, or wound healing delay at either the donor site or breast. There was one positive margin which occurred in a mastectomy patient. Significance: This study describes the use of lateral chest wall flaps in a wide variety of reconstructive breast surgery scenarios. This technique can be safely performed in an outpatient setting and does not require microvascular techniques. Review of our outcomes and complications demonstrate that this is a safe and effective option. Our experience is that this is an easy to learn, versatile flap that could be a valuable addition to the surgeon's arsenal in breast reconstruction.

Justification: Les lambeaux thoraciques latéraux constituent une option de reconstruction polyvalente, particulièrement utile par des temps de restriction globale des ressources en soins de santé. Dans cette série, nous présentons notre expérience de l'utilisation du volet latéral de paroi thoracique aussi bien en cas de reconstruction immédiate que différée pour les chirurgies de conservation du sein et pour les mastectomies. Méthodes: Une étude de cohorte rétrospective de patientes ayant subi un lambeau latéral de la paroi thoracique pour reconstruction immédiate ou différée du sein pour lumpectomie ou mastectomie a été réalisée. Les données collectées ont inclus les caractéristiques démographiques des patientes, le type de procédure, les caractéristiques de la tumeur/oncologiques ainsi que les complications postopératoires. Résultats: Entre septembre 2015 et avril 2021, vingt-six patientes ont subi une reconstruction du sein avec lambeau latéral de la paroi thoracique. Quinze patientes (58%) ont eu une reconstruction immédiate (9 lumpectomies, 6 mastectomies) et onze (42%) ont eu une reconstruction différée du sein. Tous les lambeaux ont survécu bien qu'une patiente ait nécessité un débridement partiel du lambeau après un trouble veineux, quelques heures après l'intervention chirurgicale. Il n'y a pas eu de survenue d'hématome, de sérome, d'infection ou de retard de cicatrisation au niveau du site donneur ou du sein. Des marges positives sont survenues chez une patiente mastectomisée. Signification: Cette étude décrit l'utilisation de lambeaux latéraux de la paroi thoracique dans une grande variété de scénarios de chirurgie mammaire reconstructrice. Cette technique peut être employée de manière sécuritaire dans un cadre ambulatoire et ne nécessite pas de recours à des techniques microvasculaires. L'analyse de nos résultats et des complications démontre qu'il s'agit d'une option sécuritaire et efficace. Selon notre expérience, cette technique est facile à apprendre; le lambeau polyvalent pourrait être un supplément intéressant dans l'arsenal du chirurgien pour la reconstruction mammaire. Mots-clés: reconstruction mammaire, lambeau, perforateur, oncoplastique, chirurgie de conservation mammaire, mastectomie.

Canadian Expert Opinion on Breast Reconstruction Access: Strategies to Optimize Care during COVID-19.

BACKGROUND: Breast reconstructive services are medically necessary, time-sensitive procedures with meaningful health-related quality of life benefits for breast cancer survivors. The COVID-19 global pandemic has resulted in unprecedented restrictions in surgical access, including access to breast reconstructive services. A national approach is needed to guide the strategic use of resources during times of fluctuating restrictions on surgical access due to COVID-19 demands on hospital capacity. METHODS: A national team of experts were convened for critical review of healthcare needs and development of recommendations and strategies for patients seeking breast reconstruction during the pandemic. Following critical review of literature, expert discussion by teleconference meetings, and evidenced-based consensus, best practice recommendations were developed to guide national provision of breast reconstructive services. RESULTS: Recommendations include strategic use of multidisciplinary teams for patient selection and triage with centralized coordinated use of alternate treatment plans during times of resource restrictions. With shared decision-making, patient-centered shifting and consolidation of resources facilitate efficient allocation. Targeted application of perioperative management strategies and surgical treatment plans maximize the provision of breast reconstructive services. CONCLUSIONS: A unified national approach to strategically reorganize healthcare delivery is feasible to uphold standards of patient-centered care for patients interested in breast reconstruction.

Predictive value of 3D imaging to guide implant selection in immediate breast reconstruction.

BACKGROUND: Pre-operative estimation of breast mound volume for immediate breast reconstruction is necessary for operative planning, especially in direct-to-implant reconstruction. Our purpose was to investigate the relationship between pre-operative predictions of breast mound weight from 3D imaging and actual mastectomy weight and implant size. METHODS: A retrospective chart review of all patients who had previously undergone nipple-sparing mastectomy (NSM) by a single surgeon was performed. Pre-operative 3D images were reviewed and calculations of breast mound weight were performed by three independent reviewers. Intra-operative mastectomy weight and final implant weight were collected from patient charts. A regression analysis between calculated and actual values was performed. RESULTS: There were 59 reconstructed breasts included. Pre-operative 3D imaging-guided breast weight calculations were similar across reviewers (R=0.96). Pre-operative calculations of breast weight were 49.4g (SD=134.0) smaller than actual mastectomy specimens. Mastectomy specimens were 41.0g (SD=130.2) smaller than final implant sizes. Thereby, the relationship was as follows: Pre-operative calculated breast weight < actual Mastectomy weight < implant weight. Mastectomy weight and final implant size had linear relationships with pre-operative calculations of breast weight. Formulas for predicting mastectomy weight [mastectomy weight = 63.2 + 0.95 (pre-operative calculated weight)] and implant size [Implant weight = 209.7+ 0.56 (pre-operative calculated weight)] from pre-operative calculations of breast weight were generated. CONCLUSIONS: Three-dimensional scanning technologies may be a useful tool to predict implant sizes for direct-to-implant breast reconstruction. Final implant size was heavier than intra-operative mastectomy weight and pre-operative calculated breast mound weight.

Prospective analysis of presurgical risk factors for outcomes in primary palatoplasty.

BACKGROUND: The authors present a single surgeon's series of primary palatoplasty over a 10-year period in order to determine which presurgical factors might influence postoperative fistula rate and speech outcome. METHODS: Data were prospectively acquired for all patients undergoing primary palatoplasty between January of 2000 and January of 2010. Standard demographic data were captured together with classification of cleft type and severity (as defined by palate length and cleft width). Outcome data were assessed in terms of fistula rate and the requirement for secondary speech surgery for velopharyngeal insufficiency. RESULTS: There were 485 primary procedures; 276 patients were male. Mean age at primary surgery was 20.4 months. Clefts were classified according to Kernahan and Stark (cleft palate, n = 260; cleft lip/palate, n = 225) and Veau class (I, n = 85; II, n = 175; III, n = 165; and IV, n = 60). Palate length was assessed according to Randall's classification (I, n = 81; II, n = 319; III, n = 58; IV, n = 2). Mean palate width was 7.7 mm (range, 0 to 19 mm). Cleft lip/palate was associated with wider mean cleft width and a higher incidence of shorter palates than cleft palate. Velopharyngeal insufficiency was more frequent in cleft lip/palate than in cleft palate. Male sex, greater cleft width, and shorter palate length were independent predictors of velopharyngeal insufficiency. CONCLUSIONS: Distributions of sex, cleft width, and palate length vary among the differing cleft types and may explain some of the variation in outcomes among centers and protocols. These data should be recorded to facilitate valid comparisons among future studies. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

Topical imiquimod therapy for lentigo maligna.

Lentigo maligna (LM) presents a challenge for complete surgical excision. Imiquimod is a topical immune-response modifier that acts on the immune system. We report our experience using imiquimod 5% cream as a surgical alternative for treatment of LM. Consecutive patients between December 2004 and February 2006 with LM were treated with topical imiquimod. Data on patient and lesion characteristics, side effects of therapy, posttreatment biopsy results, and follow-up was collected. Seven patients were treated with imiquimod 5 nights/wk for 12.4 weeks. Complete histologic and clinical resolution was seen in 86% (6 of 7 patients), at 19.1 months follow-up. Side effects included erythema (86%) and crusting (71%), resulting in dose alteration in 71% of patients. Topical imiquimod therapy demonstrates a high response rate for treatment of LM, with tolerable side effects. Further investigation into its efficacy in the treatment of LM in controlled clinical trials is warranted.

The perimeter technique for lentigo maligna: an alternative to Mohs micrographic surgery.

BACKGROUND: Lentigo maligna (LM) presents a challenge for complete surgical excision because of its extensive subclinical spread and predilection for the face. OBJECTIVE: To report our experience using the staged perimeter technique as an alternative to Mohs micrographic surgery for treatment of LM. METHODS: The perimeter procedure was performed on 11 patients with LM between March 2003 and June 2004. Data on patient and lesion characteristics, number of stages required to obtain clear margins, and follow-up was obtained by chart review. RESULTS: A mean of 1.9 stages were required to achieve clear margins. A mean of 7 tissue specimens were sent to pathology per patient for evaluation. After a mean follow-up of 4.7 months, all patients were free of recurrence. CONCLUSIONS: The perimeter technique is a simple method of margin-controlled excision of LM. The main advantage is that all margins are examined with permanent sections. The main drawback is that multiple operative sessions are required to complete the procedure. This technique does not require specific Mohs training and is therefore applicable to non-Mohs surgeons.